Royalty Pharma plc Class A Ordinary Shares vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.88 (market cap $25.27B), while Vivmark Residential Common Shares of Beneficial Interest trades at $61.11 (market cap $46.41B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is the larger of the two by market cap, and Vivmark Residential Common Shares of Beneficial Interest pays the higher dividend (4.68%). Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 1 Days and Vivmark Residential Common Shares of Beneficial Interest for 1 Days on average.
| RPRX | VMRK | |
|---|---|---|
Market Cap | $25.27B | $46.41B |
Volume | 3,671,183 | 6,584,008 |
Sector | Health | Real Estate |
52-Week High | $63.96 | $70.15 |
52-Week Low | $35.44 | $57.98 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $32.50B | $55.52B |
Dividend Yield | 1.66% | 4.68% |
Trailing returns across standard periods
Latest headlines on both assets
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →